AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Biomea Fusion, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00YS4WDD8
0.60▲ 0.02 (2.58%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
0.59
Day's Range
0.59 – 0.63
52-Week Range
0.58 – 2.24
Volume
947.8K
Avg Volume
2.4M
Share Statistics
Shares Outstanding
Employees
41
Exchange
XNAS
Listed
2021-04-16
Share count as of July 31, 2026

Biomea Fusion, Inc. Common Stock (BMEA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Biomea Fusion, Inc. Common Stock (BMEA)
What is Biomea Fusion, Inc. Common Stock's Market Cap?
Biomea Fusion, Inc. Common Stock's Market Cap is $43.5M, based on as-reported figures from SEC (XBRL) filings.
What is Biomea Fusion, Inc. Common Stock's Enterprise Value?
Biomea Fusion, Inc. Common Stock's Enterprise Value is $8.7M, based on as-reported figures from SEC (XBRL) filings.
What is Biomea Fusion, Inc. Common Stock's EV / EBITDA?
Biomea Fusion, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Biomea Fusion, Inc. Common Stock's Net Income (TTM)?
Biomea Fusion, Inc. Common Stock's Net Income (TTM) is -$32.5M, based on as-reported figures from SEC (XBRL) filings.
What is Biomea Fusion, Inc. Common Stock's EBITDA?
Biomea Fusion, Inc. Common Stock's EBITDA is -$57.5M, based on as-reported figures from SEC (XBRL) filings.
What is Biomea Fusion, Inc. Common Stock's Diluted EPS (TTM)?
Biomea Fusion, Inc. Common Stock's Diluted EPS (TTM) is -0.45, based on as-reported figures from SEC (XBRL) filings.
What is Biomea Fusion, Inc. Common Stock's Net Debt?
Biomea Fusion, Inc. Common Stock's Net Debt is -$34.8M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BMEAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Change in fair value of common warrant liability——
Gain on sale of property and equipment——
Interest and other income, net
Net and comprehensive loss
Net loss per common share, basic
Net loss per common share, diluted